Future Market Insights (FMI), in its report, projects the global oral controlled release drug delivery technology market to register an impressive expansion at 7.2% CAGR during the forecast period 2017 to 2027. The market will surpass revenues worth US$ 20,000 Mn in 2017, and is further estimated to reach nearly US$.
Oral Controlled Release Drug Delivery Technology Market In-Depth Analysis on Size, Cost Structure an pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Search jobs 05-Mar-2021 Oral Controlled Release Drug Delivery Technology Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- AstraZeneca Plc., Sun Pharmaceuticals Industries Ltd, Novartis AG, Mylan N.V and Others
VALLEY COTTAGE, N.Y. – Among all the routes that have been tried and tested for ensuring the accurate and systemic delivery of drugs, oral drug delivery is the most commonly used and trusted method for the administration of various pharmaceutical products. As it enables smooth delivery of drugs with various dosage forms, leading players in the pharmaceuticals industry are focusing on further improving features of oral drug delivery methods.